Affiliation:
1. Y-J.L. is at Department of Immunology and Center of Cancer Immunology Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030
Abstract
Thymic stromal lymphopoietin (TSLP) is an interleukin (IL) 7–like cytokine that triggers dendritic cell–mediated T helper (Th)2 inflammatory responses. TSLP is highly expressed by keratinocytes in skin lesions of patients with atopic dermatitis and is associated with dendritic cell activation in situ, suggesting that TSLP might be a master switch for allergic inflammation at the epithelial cell–dendritic cell interface. New reports now establish a direct link between TSLP expression and the pathogenesis of atopic dermatitis and asthma in vivo, and begin to reveal the molecular mechanisms underlying TSLP-induced allergic inflammation.
Publisher
Rockefeller University Press
Subject
Immunology,Immunology and Allergy
Cited by
494 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Asthma bronchiale: Therapie noch detaillierter durch Endotypisierung leiten;Deutsches Ärzteblatt Online;2024-08-23
2. The Role of Neuro-Immune Interactions in the Pathology and Pathogenesis of Allergic Rhinitis;Immunological Investigations;2024-07-23
3. A phase 1, randomized, double-blind, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of SHR-1905, a long-acting anti-thymic stromal lymphopoietin antibody, in healthy subjects;Frontiers in Pharmacology;2024-07-15
4. Design, synthesis, and biological evaluation of 2-(2-oxoindolin-3-ylidene)hydrazinecarbothioamides as a potential EGR-1 inhibitor for targeted therapy of atopic dermatitis;Bioorganic Chemistry;2024-07
5. Monoclonal Antibodies: Current Advancements and Future Potential for
Atopic Dermatitis Therapy;Current Pharmaceutical Biotechnology;2024-06-25